Loading patent…
AssigneeAventis Pharma S.A.
InventorsBruno Dumas, Gilles Cauet, Eric Degryse, Tilman Achstetter
Estimating the term…
The present invention relates to novel yeast strains, methods and genetic constructs for their preparation, and their use for the synthesis or modification of steroidal compounds. More particularly, the invention describes strains having a reduced 20αHSD type activity, in particular by modifying the GCY1 and/or YPR1 genes. The yeast strains of the invention make it possible to improve the efficiency of the synthesis or to increase the selectivity or the yields of the method, as well as the quality of the final product. The strains, methods and compounds of the invention are useful in the search for, the development and the production of products with therapeutic or prophylactic activity, in humans or animals, in particular of steroidal derivatives.
A method for modifying a hydroxyprogesterone compound, comprising bringing the compound into contact with a Saccharomyces cerevisiae yeast strain comprising an inactivating genetic modification in both the YPR1 and GCY1 genes and comprising a reduced 20α-hydroxysteroid dehydrogenase (20α-HSD) activity.
A method for producing 11-deoxycortisol from a hydroxyprogesterone compound, comprising bringing the hydroxyprogesterone compound into contact with a Saccharomyces cerevisiae yeast strain comprising an inactivating genetic modification in both the YPR1 and GCY1 genes and comprising a reduced 20α-hydroxysteroid dehydrogenase (20α-HSD) activity.
A method for preparing 11-deoxycortisol comprising the step of growing a Saccharomyces cerevisiae yeast strain comprising an inactivating genetic modification in both the YPR1 and GCY1 genes.
Dependencies are inferred from the claim text.